drugset / Trial / NCT03328234
Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03
RandomizedCrossoverOpen-labelTreatment
Summary
The investigators aimed to compare elective nodal irradiation versus involved field irradiation with or without concurrent chemotherapy and the addition of consolidation chemotherapy for patients with extensive lymphatic metastasis of esophageal cancer.
Timeline
- Start
- 2017-09-01
- Primary completion
- 2021-08-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 20 mg/m2 | — |
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | — |
| Subject | Cisplatin | Other / unclassified | 50 mg/m2 | — |
| Subject | Cisplatin | Other / unclassified | 80 mg/m2 | — |
| Subject | Lobaplatin | Small molecule | 20 mg/m2 | — |
| Subject | Lobaplatin | Small molecule | 25 mg/m2 | — |
| Subject | Lobaplatin | Small molecule | 50 mg | — |
| Subject | Nedaplatin | Small molecule | 20 mg/m2 | — |
| Subject | Nedaplatin | Small molecule | 25 mg/m2 | — |
| Subject | Nedaplatin | Small molecule | 50 mg/m2 | — |
| Subject | Nedaplatin | Small molecule | 80 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 45 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 50 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 135 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 150 mg/m2 | — |
Indications
No indication recorded.